Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/043073external-prioritypatent/WO2009140128A2/en
Application filed by Irm LlcfiledCriticalIrm Llc
Publication of TN2010000519A1publicationCriticalpatent/TN2010000519A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Ros, KDR, FMS, C-FMS, FLT3, c-Kit, JAK2, JAK3, Aurora, PDGFR, Lck, TrkA, TrkB, TrkC, IGF-1R, ALK4, ALK5 and ALK or combinations thereof.
TNP2010000519A2009-05-072010-11-05Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
TN2010000519A1
(en)